Pyxis Oncology Director Humphrey Rachel Sells 14,596 Shares for $14.5M.

Pyxis Oncology, Inc. (PYXS) has disclosed that Director Humphrey Rachel has recently executed a series of transactions involving the sale of shares. On April 14, 2025, Rachel sold 1,400 shares at a price of $0.97 per share. Two days later, on April 17, 2025, she sold an additional 200 shares at the same price point. Most recently, on April 21, 2025, Rachel sold a substantial 13,896 shares at $1.03 per share. These transactions indicate a significant change in Rachel's holdings within the company.